摘要
目的通过分析我国4823种中成药采购金额、日用药金额、用药频度的重叠率指标,为完善国家基本药物目录提供参考。方法重叠率。结果样本省份指标排前的中成药品种,地区之间的重叠率比较低。相同的品种主要是中药注射液。结论制定国家基本药物目录和各省增补目录中成药部分时,要在中成药地区特色和发挥规模经济效应之间取得平衡。
Objective To analyze the medication amount index, DDDS index, DDC index of the 4823 kinds of Chinese patent medicines from sales amount,aim to give proposals to perfect the National Essential Medicine List. Methods Overlap rate method. Results The ovedap rate of Chinese medicine with ranking forward is very low among sample provinces.The same varieties are Chinese medicine injection. Conclusion To perfect National Essential Medicine List and each province's list, there should be a balance between Chinese medicine's region features and the economies of scale.
出处
《中国药物经济学》
2013年第2期25-28,共4页
China Journal of Pharmaceutical Economics
基金
广东省中医药局课题:广东中成药企业品种销售和使用区域性差异研究
项目编号:20113003
国家卫生部委托课题:中成药品种和使用区域性差异研究(2011)
关键词
中成药
重叠率
采购金额
日用药金额
用药频度
Chinese Medicine
Overlap rate
Mmedication amount
Defined daily consumption
Frequency ofmedicine use